Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

861: Non-Viral Cell Engineering of Peripheral Blood Natural Killer Cells Using a GMP-Compliant, Scalable Electroporation Platform

Disclosures:   L.E. Unsworth: 1; Commercial Interest i.e. Company X; MaxCyte, Inc. 1; What was received? i.e. Honorarium; Salary. 1; For what role? i.e. Speaker; Employment.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.